US Physical Therapy director buys 780 shares

U.S. Physical Therapy director Peter Francis Minan reported buying company stock in the open market.

Rhea-AI Filing Summary

U.S. Physical Therapy director Peter Francis Minan reported buying company stock in the open market. He purchased 492 shares of common stock on June 8, 2026 at $63.14 per share and 288 shares on June 9, 2026 at $61.50 per share, totaling 780 shares.

After these trades, he directly holds 3,211 common shares. Footnotes state this includes 2,306 shares granted as restricted stock, with restrictions scheduled to lapse on August 20, 2026, November 20, 2026, and March 6, 2027 if he remains a director on those dates.

Insider Trade Summary

Net Buyer: 780 shares

Net Buy 2 txns

Insider Minan Peter Francis

Role Director

Bought 780 shs ($49K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	288	$61.50	$18K
Purchase	Common Stock	492	$63.14	$31K

Holdings After Transaction: Common Stock — 3,211 shares (Direct)

Footnotes (1)

1. F1. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Key Figures

Shares bought June 8, 2026: 492 shares at $63.14 Shares bought June 9, 2026: 288 shares at $61.50 Total shares bought: 780 shares +5 more

8 metrics

Shares bought June 8, 2026 492 shares at $63.14 Open-market purchase of common stock

Shares bought June 9, 2026 288 shares at $61.50 Open-market purchase of common stock

Total shares bought 780 shares Net-buy across two open-market transactions

Direct holdings after transactions 3,211 shares Common stock held directly following the reported purchases

Restricted stock included 2,306 shares Granted under 2003 Stock Incentive Plan, subject to vesting

Vesting tranche August 20, 2026 1,153 shares Restrictions lapse if he is a director on that date

Vesting tranche November 20, 2026 576 shares Restricted stock vesting conditionally on service

Vesting tranche March 6, 2027 577 shares Restricted stock vesting conditionally on service

Key Terms

open-market purchase, restricted stock, Company Amended and Restated 2003 Stock Incentive Plan

3 terms

open-market purchase financial

"transaction_action: open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

restricted stock financial

"Includes 2,306 shares which were granted as restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Company Amended and Restated 2003 Stock Incentive Plan financial

"granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did USPH director Peter Francis Minan report?

Peter Francis Minan reported open-market purchases of USPH common stock totaling 780 shares. He bought 492 shares at $63.14 on June 8, 2026 and 288 shares at $61.50 on June 9, 2026, increasing his direct ownership stake.

At what prices did USPH director Minan buy U S Physical Therapy (USPH) shares?

Minan purchased U S Physical Therapy common stock at $63.14 and $61.50 per share. He acquired 492 shares at $63.14 on June 8, 2026 and 288 shares at $61.50 on June 9, 2026 in open-market transactions.

How many U S Physical Therapy (USPH) shares does Minan own after these trades?

Following the reported purchases, Minan directly owns 3,211 U S Physical Therapy common shares. This figure includes 2,306 shares granted as restricted stock that vest over time, assuming he continues serving as a director on specified future dates.

What restricted stock awards does USPH director Minan hold?

Minan holds 2,306 U S Physical Therapy shares as restricted stock under the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on 1,153 shares August 20, 2026, 576 shares November 20, 2026, and 577 shares March 6, 2027 if he remains a director.

Are Minan’s U S Physical Therapy (USPH) purchases open-market transactions?

Yes, both transactions are coded as open-market purchases of U S Physical Therapy common stock. The Form 4 describes them as purchases in open market or private transactions, with no derivative exercises or sales reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 06:36 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Minan Peter Francis

(Last) (First) (Middle)

1300 W SAM HOUSTON PKWAY S, SUITE 300

(Street)

HOUSTON TEXAS 77042

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/08/2026		P		492	A	$63.14	2,923(1)	D
Common Stock	06/09/2026		P		288	A	$61.5	3,211(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

	Kate Venturina	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)